SCPHARMACEUTICALS INC (SCPH) Stock Income Statement
NASDAQ:SCPH - Nasdaq - US8106481059 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 30.28M | 13.59M | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 9.17M | 3.81M | N/A | N/A | N/A | |||
| Gross Profit | 21.11M | 9.78M | N/A | N/A | N/A | |||
| Operating Expenses | 84.80M | 65.18M | 36.16M | 25.82M | 29.93M | |||
| Research and Development | 12.28M | 11.81M | 15.53M | 16.04M | 18.15M | |||
| Selling, General, and Administrative Expenses | 72.52M | 53.37M | 20.62M | 9.78M | 11.78M | |||
| Operating Income | -63.69M | -55.40M | -36.16M | -25.82M | -29.93M | |||
| Interest Income/Expense | -7.56M | -3.02M | -2.10M | -2.53M | -2.27M | |||
| Other Income/Expense | 4.17M | 3.60M | 1.42M | 320.00K | 0.00 | |||
| Income Before Taxes | -80.11M | -54.81M | -36.84M | -28.03M | -32.21M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -80.11M | -54.81M | -36.84M | -28.03M | -32.21M | |||
| EBITDA | -63.60M | -54.77M | -36.12M | -25.79M | -29.90M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.91 | -1.42 | -1.30 | -1.14 | -1.31 | |||
| Non GAAP EPS | -1.90 | -1.42 | -1.30 | -1.03 | -1.32 | |||
| Statistics | ||||||||
| Gross Profit Margin | 69.72% | 71.96% | N/A | N/A | N/A | |||
| Profit Margin | -264.60% | -403.22% | N/A | N/A | N/A | |||
| Operating Profit Margin | -210.35% | -407.53% | N/A | N/A | N/A | |||
All data in USD